Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. Am J Ophthalmol 2001 Dec;132(6):945-7
Date
12/04/2001Pubmed ID
11730673DOI
10.1016/s0002-9394(01)01141-2Scopus ID
2-s2.0-0035205734 (requires institutional sign-in at Scopus site) 50 CitationsAbstract
PURPOSE: To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha.
METHODS: Interventional case report.
RESULTS: The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy.
CONCLUSION: Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.
Author List
Esmaeli B, Ahmadi A, Tang R, Schiffman J, Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
ExophthalmosGranuloma
Histiocytosis, Non-Langerhans-Cell
Humans
Interferon-alpha
Magnetic Resonance Imaging
Male
Middle Aged
Orbital Diseases
Osteosclerosis
Radionuclide Imaging
Technetium Tc 99m Medronate
Visual Acuity
Xanthomatosis